GlassScriptPhysician profile
Emmanuel P Brown
NPI 1841397601
$2,365.09
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $759 · 2020: $657 · 2021: $936 · 2022: $14.01.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $418.08 | 2019-2021 | |
| Gilead Sciences, INC. | $335.00 | 2019-2021 | |
| Glaxosmithkline, LLC. | $315.58 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $190.16 | 2019-2020 | |
| Pfizer INC. | $138.07 | 2019-2021 | |
| Novo Nordisk INC | $130.96 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $123.95 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $114.98 | 2019 | |
| Abbvie INC. | $106.71 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $70.39 | 2019-2021 | |
| Amarin Pharma, INC. | $62.92 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.62 | 2019 | |
| Eisai INC. | $58.78 | 2021 | |
| Allergan, INC. | $39.92 | 2020 | |
| Hologic Sales and Service, LLC | $38.36 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $36.88 | 2019-2020 | |
| Viiv Healthcare Company | $27.11 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.78 | 2019 | |
| Horizon Therapeutics Plc | $18.13 | 2019 | |
| Smith+Nephew, INC. | $16.28 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.13 | 2021 | |
| Mission Pharmacal Company | $14.05 | 2019 | |
| Eyevance Pharmaceuticals LLC | $12.25 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuel Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.